Legal Representation
Attorney
Joseph E. Washington
USPTO Deadlines
Next Deadline
1707 days remaining
Section 8 (6-Year) Declaration Due (Based on registration date 2024-03-12)
Due Date
March 12, 2030
Grace Period Ends
September 12, 2030
Additional deadlines exist. Contact your attorney for complete deadline information.
Application History
50 eventsDate | Code | Type | Description |
---|---|---|---|
Mar 12, 2024 | R.PR | A | REGISTERED-PRINCIPAL REGISTER |
Mar 12, 2024 | NRCC | E | NOTICE OF REGISTRATION CONFIRMATION EMAILED |
Feb 8, 2024 | SUNA | E | NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED |
Feb 7, 2024 | CNPR | P | ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED |
Feb 5, 2024 | ALIE | A | ASSIGNED TO LIE |
Feb 5, 2024 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Feb 5, 2024 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Aug 7, 2023 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
May 8, 2023 | CNRT | W | SU - NON-FINAL ACTION - WRITTEN |
May 8, 2023 | GNRT | O | NON-FINAL ACTION E-MAILED |
May 8, 2023 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Mar 25, 2023 | AITU | A | CASE ASSIGNED TO INTENT TO USE PARALEGAL |
Mar 25, 2023 | SUPC | I | STATEMENT OF USE PROCESSING COMPLETE |
Mar 13, 2023 | EISU | I | TEAS STATEMENT OF USE RECEIVED |
Mar 13, 2023 | IUAF | S | USE AMENDMENT FILED |
Sep 13, 2022 | NOAM | E | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
Jul 19, 2022 | PUBO | A | PUBLISHED FOR OPPOSITION |
Jul 19, 2022 | NPUB | E | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
Jun 29, 2022 | NONP | E | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
Jun 16, 2022 | CNSA | P | APPROVED FOR PUB - PRINCIPAL REGISTER |
Jun 1, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Jun 1, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
May 31, 2022 | ERFR | I | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
Feb 28, 2022 | CFRC | R | SUBSEQUENT FINAL REFUSAL WRITTEN |
Feb 28, 2022 | GNSF | O | SUBSEQUENT FINAL EMAILED |
Feb 28, 2022 | GNS1 | O | NOTIFICATION OF SUBSEQUENT FINAL EMAILED |
Jan 25, 2022 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Jan 25, 2022 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Jan 18, 2022 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Jul 18, 2021 | CNRT | R | NON-FINAL ACTION WRITTEN |
Jul 18, 2021 | GNRT | O | NON-FINAL ACTION E-MAILED |
Jul 18, 2021 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
Jun 4, 2021 | ALIE | A | ASSIGNED TO LIE |
Jun 4, 2021 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Jun 4, 2021 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Mar 8, 2021 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Sep 10, 2020 | DOCK | D | ASSIGNED TO EXAMINER |
Sep 10, 2020 | DOCK | D | ASSIGNED TO EXAMINER |
Sep 10, 2020 | CNRT | R | NON-FINAL ACTION WRITTEN |
Sep 10, 2020 | GNRT | O | NON-FINAL ACTION E-MAILED |
Sep 10, 2020 | GNRN | O | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
May 23, 2020 | CNFR | R | FINAL REFUSAL WRITTEN |
May 23, 2020 | GNFR | O | FINAL REFUSAL E-MAILED |
May 23, 2020 | GNFN | O | NOTIFICATION OF FINAL REFUSAL EMAILED |
May 1, 2020 | TEME | I | TEAS/EMAIL CORRESPONDENCE ENTERED |
Apr 30, 2020 | TROA | I | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
Apr 30, 2020 | CRFA | I | CORRESPONDENCE RECEIVED IN LAW OFFICE |
Feb 3, 2020 | DOCK | D | ASSIGNED TO EXAMINER |
Oct 30, 2019 | CNRT | R | NON-FINAL ACTION WRITTEN |
Oct 30, 2019 | GNRT | F | NON-FINAL ACTION E-MAILED |
Detailed Classifications
Class 045
Licensing of intellectual property used in the creation of financial instruments
First Use Anywhere:
Jun 7, 2011
First Use in Commerce:
Jun 7, 2011
Additional Information
Design Mark
The mark consists of a stylized representation of a shield intersected by a curved line; directly to the right of the shield is the word "PRECIDIAN" stacked on top of the word "INVESTMENTS".
Color Claim
Color is not claimed as a feature of the mark.
Classification
International Classes
045
Disclaimers
The following terms have been disclaimed and are not claimed as part of the trademark:
General Disclaimer
"INVESTMENTS"